Clinical Trial Update: Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating colchicine for progression of coronary atherosclerosis in patients with TET2-CHIP variant; the study is currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Hematopoiesis of Indeterminate Potential
• Coronary Atherosclerosis

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Colchicine, Coronary Atherosclerosis Management | Phase 4 | Status: NOT_YET_RECRUITING